drugset / Trial / NCT04552977
A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
NaSingle-groupOpen-labelTreatment
Summary
This is a one arm, open, single center phase II study. The main purpose of this study was to evaluate the efficacy and safety of fluzoparil combined with temozolomide in patients with recurrent glioblastoma.
Timeline
- Start
- 2020-09
- Primary completion
- 2021-08
- Completion
- 2022-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluzoparil | Unknown | — | — |
| Subject | Temozolomide | Small molecule | — | — |